These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33613103)

  • 1. Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma.
    Song A; Wu Y; Chu W; Yang X; Zhu Z; Yan E; Zhang W; Zhou J; Ding X; Liu J; Zhu H; Ye J; Wu Y; Zheng Y; Song X
    Int J Biol Sci; 2021; 17(2):430-447. PubMed ID: 33613103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
    Yan J; Xu H
    Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
    Wang J; Jia J; Zhou L
    Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X; Yang B; Liu F; Fang Q
    Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
    Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal-mediated transfer of APCDD1L-AS1 induces 5-fluorouracil resistance in oral squamous cell carcinoma via miR-1224-5p/nuclear receptor binding SET domain protein 2 (NSD2) axis.
    Li S; Shi Z; Fu S; Li Q; Li B; Sang L; Wu D
    Bioengineered; 2021 Dec; 12(1):7188-7204. PubMed ID: 34546854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.
    Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
    Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 12. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
    Wang X; Zhang Y; Zhang S; Duan L
    Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
    Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
    Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.
    Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L
    Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0058063 Contributed to Oral Squamous Cell Carcinoma Development by Sponging miR-145 and Regulating PI3K/AKT Pathway.
    Zhou J; Jin S
    Mol Biotechnol; 2023 Dec; 65(12):2049-2060. PubMed ID: 36928742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
    Wu J; Li Y; Liu J; Xu Y
    J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase
    Gao F; Han J; Wang Y; Jia L; Luo W; Zeng Y
    Cancer Biother Radiopharm; 2022 May; 37(4):233-245. PubMed ID: 32758011
    [No Abstract]   [Full Text] [Related]  

  • 20. LncRNA LSINCT5 drives proliferation and migration of oral squamous cell carcinoma through the miRNA-185-5p/ZNF703 axis.
    Wang X; Feng X; Wang H
    J BUON; 2021; 26(1):124-131. PubMed ID: 33721442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.